This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre Hospitalier Universitaire De Brest, National Institute of Health and Medical Research, Neurochlore. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4 
1 out of 1,853 
1 out of 1 
Years Active: 2019
Title: Nail Burnashev: Innovator in Treating Fragile X Syndrome
Introduction
Nail Burnashev is a prominent inventor based in Marseille, France. He has made significant contributions to the field of medical science, particularly in the treatment of neurological disorders. His innovative work focuses on developing solutions for conditions that affect cognitive function and behavior.
Latest Patents
Nail Burnashev holds a patent for "Modulators of intracellular chloride concentration for treating fragile X syndrome." This composition is designed to treat Fragile X syndrome in individuals who require intervention. The formulation includes an effective amount of a modulator of a chloride transporter, showcasing his commitment to advancing therapeutic options for this condition. He has 1 patent to his name.
Career Highlights
Throughout his career, Nail Burnashev has worked with notable organizations such as Neurochlore and Université d'Aix-Marseille. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Nail has collaborated with esteemed colleagues, including Eric Lemonnier and Yehezkel Ben-Ari. These partnerships have enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Nail Burnashev's innovative contributions to the treatment of Fragile X syndrome highlight his dedication to improving the lives of those affected by neurological disorders. His work continues to inspire advancements in medical research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile